ConductScience.org, home
Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face
API referenceFor AI assistants

Trial · NCT04085367

Adverse events30

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 30

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherActinic keratosisSkin and subcutaneous tissue disordersMAL 16.8% Cream62364
otherActinic keratosisSkin and subcutaneous tissue disordersMAL Vehicle Cream30193
otherSkin lesionSkin and subcutaneous tissue disordersMAL 16.8% Cream4364
otherSkin lesionSkin and subcutaneous tissue disordersMAL Vehicle Cream2193
otherApplication site painGeneral disordersMAL 16.8% Cream11364
otherApplication site painGeneral disordersMAL Vehicle Cream2193
otherApplication site erythemaGeneral disordersMAL 16.8% Cream12364
otherApplication site erythemaGeneral disordersMAL Vehicle Cream0193
otherApplication site dermatitisGeneral disordersMAL 16.8% Cream7364
otherApplication site dermatitisGeneral disordersMAL Vehicle Cream1193
otherApplication site pruritusGeneral disordersMAL 16.8% Cream5364
otherApplication site pruritusGeneral disordersMAL Vehicle Cream3193
otherPost procedural haemorrhageInjury, poisoning and procedural complicationsMAL 16.8% Cream7364
otherPost procedural haemorrhageInjury, poisoning and procedural complicationsMAL Vehicle Cream3193
otherBasal cell carcinomaNeoplasms benign, malignant and unspecified (incl cysts and polyps)MAL 16.8% Cream4364
otherBasal cell carcinomaNeoplasms benign, malignant and unspecified (incl cysts and polyps)MAL Vehicle Cream4193
seriousBack injuryInjury, poisoning and procedural complicationsMAL 16.8% Cream1364
seriousBack injuryInjury, poisoning and procedural complicationsMAL Vehicle Cream0193
seriousHip fractureInjury, poisoning and procedural complicationsMAL 16.8% Cream1364
seriousHip fractureInjury, poisoning and procedural complicationsMAL Vehicle Cream1193

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04085367/events

API referenceFor AI assistants